• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Value of ascitic lipids in the differentiation between cirrhotic and malignant ascites.

作者信息

Jüngst D, Gerbes A L, Martin R, Paumgartner G

出版信息

Hepatology. 1986 Mar-Apr;6(2):239-43. doi: 10.1002/hep.1840060214.

DOI:10.1002/hep.1840060214
PMID:3957233
Abstract

Ascitic fluid concentrations of cholesterol, triglycerides and phospholipids, were compared with ascitic fluid total protein in 40 patients with chronic liver disease, 51 patients with various neoplasms and 1 patient with cardiac failure. Seven patients with both chronic liver disease and malignancy were considered separately. The first 54 patients (23 cirrhotic and 31 with malignancy) were used to determine median values and ranges and to define the most suitable cutoff concentrations between both groups. Median values for cholesterol (75 mg per dl), phospholipids 0.79 mmole per liter), triglycerides (75 mg per dl) and protein (3.8 gm per dl) were higher in malignant ascites compared to ascitic fluid concentrations of cholesterol (20 mg per dl), phospholipids (0.33 mmole per liter), triglycerides (51 mg per dl) and protein (1.9 gm per dl) in patients with cirrhosis. The best discrimination values were 48 mg per dl for cholesterol, 0.6 mmole per liter for phospholipids, 65 mg per dl for triglycerides and 2.5 gm per dl for protein. Application of these cutoff points to 38 subsequent patients (17 cirrhotic, 1 with cardiac failure and 20 with malignancy) revealed an efficiency of 86.8% for cholesterol, 86.8% for phospholipids, 68.4% for triglycerides and 79.0% for protein. From the data of all 92 patients, an efficiency of 92.3% for cholesterol, 79.4% for phospholipids, 72.8% for triglycerides and 79.4% for protein was calculated. We conclude that ascitic fluid cholesterol determination offers an excellent, cost-effective discrimination of ascites due to cirrhosis vs. ascites caused by malignancies.

摘要

相似文献

1
Value of ascitic lipids in the differentiation between cirrhotic and malignant ascites.
Hepatology. 1986 Mar-Apr;6(2):239-43. doi: 10.1002/hep.1840060214.
2
Diagnosis of malignant ascites. Comparison of ascitic fibronectin, cholesterol, and serum-ascites albumin difference.恶性腹水的诊断。腹水纤维连接蛋白、胆固醇及血清-腹水白蛋白梯度的比较。
Dig Dis Sci. 1988 Jul;33(7):833-8. doi: 10.1007/BF01550972.
3
[Biochemical markers of the tumor origin of ascites].
Pathol Biol (Paris). 1989 Jun;37(6):720-4.
4
[Concentration of lipids in ascitic fluid and the concentration gradient of albumin in blood and ascites: diagnostic significance].[腹水脂质浓度及血液与腹水白蛋白浓度梯度:诊断意义]
Ann Gastroenterol Hepatol (Paris). 1989 Nov;25(6):251-6.
5
[Value of ascitic lipids and sero-ascitic gradient of albumin in the differential diagnosis of ascites].[腹水脂质及血清-腹水白蛋白梯度在腹水鉴别诊断中的价值]
Acta Med Port. 1989 Jan-Feb;2(1):17-20.
6
Ascitic fluid concentrations of fibronectin and cholesterol: comparison of differential diagnostic value with the conventional protein determination.腹水纤维连接蛋白和胆固醇浓度:与传统蛋白质测定的鉴别诊断价值比较
Liver. 1990 Jun;10(3):152-7. doi: 10.1111/j.1600-0676.1990.tb00451.x.
7
Diagnosing ascites: value of ascitic fluid total protein, albumin, cholesterol, their ratios, serum-ascites albumin and cholesterol gradient.腹水的诊断:腹水总蛋白、白蛋白、胆固醇及其比值、血清-腹水白蛋白梯度和血清-腹水胆固醇梯度的价值
J Gastroenterol Hepatol. 1995 May-Jun;10(3):295-9. doi: 10.1111/j.1440-1746.1995.tb01096.x.
8
[Chylous ascites in cirrhotic and non-cirrhotic patients].[肝硬化和非肝硬化患者的乳糜性腹水]
Gastroenterol Hepatol. 1997 Jun-Jul;20(6):291-4.
9
[Ascitic fluid: the value of various biological tests in the differential diagnosis between cirrhotic and neoplastic ascites].[腹水:各种生物学检测在肝硬化腹水与肿瘤性腹水鉴别诊断中的价值]
Acta Gastroenterol Belg. 1990 Mar-Apr;53(2):168-79.
10
Fibronectin, cholesterol and triglycerides ascitic fluid concentration in the prediction of malignancy.
Ital J Gastroenterol. 1991 May;23(4):179-86.

引用本文的文献

1
Calcium Channel Blocker-Associated Chyloperitoneum in Patients Receiving Peritoneal Dialysis: A Systematic Review.钙通道阻滞剂相关乳糜性腹水在腹膜透析患者中的系统评价。
Int J Environ Res Public Health. 2019 Apr 13;16(8):1333. doi: 10.3390/ijerph16081333.
2
Isolated chylous injury due to blunt abdominal trauma: Report of a case and a review of the literature.钝性腹部创伤所致孤立性乳糜损伤:1例报告及文献复习
Turk J Surg. 2015 Jul 6;33(2):119-122. doi: 10.5152/UCD.2015.2925. eCollection 2017.
3
Diagnostic accuracy of ascitic cholesterol concentration for malignant ascites: a meta-analysis.
腹水胆固醇浓度对恶性腹水的诊断准确性:一项荟萃分析。
Int J Clin Exp Med. 2015 Oct 15;8(10):18494-9. eCollection 2015.
4
Value of ascitic fluid cholesterol and serum-ascites albumin gradient in differentiating cirrhotic and malignancy related ascites.腹水胆固醇及血清-腹水白蛋白梯度在鉴别肝硬化和恶性肿瘤相关性腹水中的价值。
Indian J Clin Biochem. 2001 Jan;16(1):106-9. doi: 10.1007/BF02867577.
5
Value of combined detection of AFU and TCH in differential diagnosis between malignant and non-tuberculous benign ascites.联合检测 AFP 和 TCH 在恶性与非结核性良性腹水鉴别诊断中的价值。
Med Oncol. 2011 Dec;28 Suppl 1:S670-4. doi: 10.1007/s12032-010-9731-9. Epub 2010 Nov 2.
6
Chylous ascites secondary to hyperlipidemic pancreatitis with normal serum amylase and lipase.血清淀粉酶和脂肪酶正常的高脂血症性胰腺炎继发乳糜性腹水。
World J Gastroenterol. 2007 Jan 21;13(3):480-2. doi: 10.3748/wjg.v13.i3.480.
7
Discrimination between malignant and nonmalignant ascites using serum and ascitic fluid proteins in a multivariate analysis model.在多变量分析模型中使用血清和腹水蛋白质鉴别恶性与非恶性腹水。
Dig Dis Sci. 2000 Mar;45(3):500-8. doi: 10.1023/a:1005437005811.
8
Diagnosis of malignant ascites. Comparison of ascitic fibronectin, cholesterol, and serum-ascites albumin difference.恶性腹水的诊断。腹水纤维连接蛋白、胆固醇及血清-腹水白蛋白梯度的比较。
Dig Dis Sci. 1988 Jul;33(7):833-8. doi: 10.1007/BF01550972.
9
Tumour associated antigens in diagnosis of serous effusions.肿瘤相关抗原在浆液性积液诊断中的应用
J Clin Pathol. 1988 Jun;41(6):633-43. doi: 10.1136/jcp.41.6.633.
10
Serum-ascites albumin gradients in nonalcoholic liver disease.
Dig Dis Sci. 1990 Jan;35(1):33-7. doi: 10.1007/BF01537219.